Ignite Creation Date:
2025-12-24 @ 9:25 PM
Ignite Modification Date:
2026-01-02 @ 8:40 AM
Study NCT ID:
NCT04998032
Status:
COMPLETED
Last Update Posted:
2024-12-06
First Post:
2021-07-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Efficacy and Safety of Supaglutide in Type 2 Diabetes Patients On Metformin Treatment(SUPER-2)
Sponsor:
Shanghai Yinnuo Pharmaceutical Technology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-12
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-15
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-08-13
Completion Date Type:
ACTUAL
First Submit Date:
2021-07-28
First Submit QC Date:
None
Study First Post Date:
2021-08-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-05
Last Update Post Date:
2024-12-06
Last Update Post Date Type:
ACTUAL